Antipsychotic treatments; focus on lurasidone

Por Sumiyoshi, Tomiki
Publicado em 2013

Cognitive Deficits in Schizophrenia and Other Neuropsychiatric Disorders: Convergence of Preclinical and Clinical Evidence

Por Stuchlik, Ales, Sumiyoshi, Tomiki
Publicado no Front Behav Neurosci (2014)

Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia

Por Sumiyoshi, Tomiki, Higuchi, Yuko, Uehara, Takashi
Publicado em 2013

Tandospirone, a 5-HT(1A) partial agonist, ameliorates aberrant lactate production in the prefrontal cortex of rats exposed to blockade of N-methy-D-aspartate receptors; Toward the...

Por Uehara, Takashi, Matsuoka, Tadasu, Sumiyoshi, Tomiki
Publicado em 2014

Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia

Por Sumiyoshi, Tomiki, Kunugi, Hiroshi, Nakagome, Kazuyuki
Publicado no Front Neurosci (2014)

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report

Por Narita, Zui, Takano, Harumasa, Sumiyoshi, Tomiki
Publicado no Neuropsychiatr Dis Treat (2017)

New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function

Por Jeon, Won Je, Sumiyoshi, Tomiki, Kurachi, Masayoshi
Publicado no Curr Neuropharmacol (2015)

Electrophysiological and Neuropsychological Predictors of Conversion to Schizophrenia in At-Risk Subjects

Por Sumiyoshi, Tomiki, Miyanishi, Tomohiro, Seo, Tomonori, Higuchi, Yuko
Publicado em 2013

LORETA Current Source Density for Duration Mismatch Negativity and Neuropsychological Assessment in Early Schizophrenia

Por Miyanishi, Tomohiro, Sumiyoshi, Tomiki, Higuchi, Yuko, Seo, Tomonori, Suzuki, Michio
Publicado em 2013

Mismatch Negativity and Cognitive Performance for the Prediction of Psychosis in Subjects with At-Risk Mental State

Por Higuchi, Yuko, Sumiyoshi, Tomiki, Seo, Tomonori, Miyanishi, Tomohiro, Kawasaki, Yasuhiro, Suzuki, Michio
Publicado em 2013

T-817MA, but Not Haloperidol and Risperidone, Restores Parvalbumin-Positive γ-Aminobutyric Acid Neurons in the Prefrontal Cortex and Hippocampus of Rats Transiently Exposed to MK-8...

Por Uehara, Takashi, Sumiyoshi, Tomiki, Seo, Tomonori, Matsuoka, Tadasu, Itoh, Hiroko, Kurachi, Masayoshi
Publicado em 2012

Mismatch Negativity and P3a/Reorienting Complex in Subjects with Schizophrenia or At-Risk Mental State

Por Higuchi, Yuko, Seo, Tomonori, Miyanishi, Tomohiro, Kawasaki, Yasuhiro, Suzuki, Michio, Sumiyoshi, Tomiki
Publicado em 2014

Does Sleep Improve Memory Organization?

Por Takeuchi, Masashi, Furuta, Hisakazu, Sumiyoshi, Tomiki, Suzuki, Michio, Ochiai, Yoko, Hosokawa, Munehito, Matsui, Mie, Kurachi, Masayoshi
Publicado em 2014

Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype

Por Uno, Kyosuke, Kikuchi, Yuu, Iwata, Mina, Uehara, Takashi, Matsuoka, Tadasu, Sumiyoshi, Tomiki, Okamoto, Yoshinori, Jinno, Hideto, Takada, Tatsuyuki, Furukawa-Hibi, Yoko, Nabeshima, Toshitaka, Miyamoto, Yoshiaki, Nitta, Atsumi
Publicado no PLoS One (2016)

Criterion and Construct Validity of the CogState Schizophrenia Battery in Japanese Patients with Schizophrenia

Por Yoshida, Taisuke, Suga, Motomu, Arima, Kunimasa, Muranaka, Yasuko, Tanaka, Tsunehiko, Eguchi, Satoshi, Lin, Crystal, Yoshida, Sumiko, Ishikawa, Masanori, Higuchi, Yuko, Seo, Tomonori, Ueoka, Yoshinori, Tomotake, Masahito, Kaneda, Yasuhiro, Darby, David, Maruff, Paul, Iyo, Masaomi, Kasai, Kiyoto, Higuchi, Teruhiko, Sumiyoshi, Tomiki, Ohmori, Tetsuro, Takahashi, Kiyohisa, Hashimoto, Kenji
Publicado em 2011

Neuroendocrinology and Behavior

Publicado em 2012

Psychoneurobiology Research and Personalized Treatment of Schizophrenia

Publicado em 2022

Cognitive Enhancement in Psychiatric Disorders

Publicado em 2019